Two clinical trials investigating semaglutide (Ozempic, Wegovy) as an early Alzheimer's treatment are expected to wrap up in ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

The effects that a pause may have on your body may depend on why you're taking the medication in the first place.

A second study has linked semaglutide, the active ingredient in Ozempic, to a condition that can cause permanent vision loss.

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.

The condition is more common in people who are overweight or obese. Similar to semaglutide treatments like Ozempic and Wegovy ...

Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...

Financial analyst assesses the credit market concerns and declining operating results for WW International, with insight on ...

Tiny doses of the weight-loss drug can sidestep its unpleasant side effects, say influencers. But is customising the dose a ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Nausea is the most common side effect of semaglutide, the ...

It's that time of the year; We all likely indulged more than we'd like to admit for the holidays and put on a few extra ...